Taken together, these data suggest that the METTL3-FBXW7 axis contributes to inhibition of tumor growth in vivo and that targeting m6A-modified FBXW7 is a promising strategy for overcoming tumorigenesis in LUAD. This evidence concerns the gene FBXW7 and neoplasm.